Rebecca Med is a Biotechnology startup founded in 2015. The company focuses on utilizing precision-controlled MEMS radio frequency technology for clinical disease control and rehabilitation. Its core team, with extensive experience from the University of California and Fortune 500 medical and electronic equipment companies, has developed micro-radio frequency technology independently, surpassing similar products from Europe and America.
Collaborating with domestic university research institutes and top hospitals in Beijing, Shanghai, and Hangzhou, Rebecca Med is dedicated to providing innovative medical solutions to professional caregivers. The recent Series A investment of CNY65.00M on 01 February 2024 was led by Med-Fine Capital and Puhua Capital. The company has honed its technical expertise in micro-devices, RF, and device integration through years of practical experience in micro-electronics and clinical innovation.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | CNY65.00M | 2 |
|
01 Feb 2024 |
| Series A | Unknown | 1 |
|
05 Nov 2020 |
| Series A | CNY15.00M | 3 |
|
31 Mar 2018 |
No recent news or press coverage available for Rebbeca Med.
We care about your data, and we'd love to use cookies make your experience better.
